| Long name: |
Recombinant Guinea pig Ras-related C3 botulinum toxin substrate 2 (RAC2) |
| Alternative names: |
Ras-related C3 botulinum toxin substrate 2, p21-Rac2, Ras-related C3 botulinum toxin substrate 2 |
| Gene name: |
RAC2 |
| Other gene names: |
RAC2 |
| General description: |
All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, Ras-related C3 botulinum toxin substrate 2 (RAC2) is a recombinant protein expressed in Mammalian Cell |
| Product category: |
Recombinant Proteins |
| Expression system: |
Mammalian Cell |
| Available also expressed in:: |
Baculovirus , Mammalian Cell, Yeast , E Coli |
| Purity: |
Greater than 90% (determined by SDS-PAGE) |
| Form: |
Lyophilized protein |
| Storage: |
Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius |
| Applications: |
IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA |
| Description: |
After mouzes and rats , also called the , cDNAs of Guinea pigs are also very popular, Guinea pig ELISA kits for plasma and sera samples are used to study human genes through the , Guinea pigs are easy in maintained laboratory animals, cavy , guinea pig , model (Cavia porcellus), rodent model |
| Gene target: |
Ras-related C3 botulinum substrate 2 (RAC2) |
| Short name: |
pig Ras-related C3 botulinum substrate 2 (RAC2) |
| Alternative name: |
small GTP binding protein Rac2)), Guinea swine Ras-related complement component 3 botulinum toxin substrate 2 (ras-related complement component 3 botulinum toxin substrate 2 (rho family |
| Alternative to gene target: |
AHUS5 and ARMD9 and ASP and C3a and C3b and CPAMD1 and HEL-S-62p, BT, C3 and IDBG-193788 and ENSMUSG00000024164 and 102642251, C3 and IDBG-21798 and ENSG00000125730 and 718, C5L2 anaphylatoxin chemotactic receptor binding, EN-7 and Gx and HSPC022 and p21-Rac2, Extracellular, GTP binding, RAC2 and IDBG-638195 and ENSBTAG00000011043 and 327671, RAC2 and IDBG-6499 and ENSG00000128340 and 5880, Rac2 and IDBG-159514 and ENSMUSG00000033220 and 19354, alternative pathway and biological process this GO :0006958 and complement activation, classical pathway and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0010575 and positive regulation vascular endothelial growth factor production and biological process this GO :0010828 and positive regulation of glucose transport and biological process this GO :0010866 and regulation of triglyceride biosynthetic process and biological process this GO :0010884 and positive regulation of lipid storage and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0030449 and regulation of complement activation and biological process this GO :0031715 and C5L2 anaphylatoxin chemotactic receptor binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045745 and positive regulation of G-protein coupled receptor protein signaling pathway and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0050766 and positive regulation of pha this GO cytosis and biological process this GO :0050776 and regulation of immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, complement component 3, nuclei, small GTP binding protein Rac2), this GO :0001798 and positive regulation of type IIa hypersensitivity and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0001970 and positive regulation of activation of membrane attack complex and biological process this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006631 and fatty acid metabolic process and biological process this GO :0006954 and inflammatory response and biological process this GO :0006955 and immune response and biological process this GO :0006956 and complement activation and biological process this GO :0006957 and complement activation, this GO :0003924 and GTPase activity and molecular function this GO :0005525 and GTP binding and molecular function this GO :0005622 and intracellular and cellular component this GO :0005635 and nuclear envelope and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006184 and GTP catabolic process and biological process this GO :0006886 and intracellular protein transport and biological process this GO :0006913 and nucleocytoplasmic transport and biological process this GO :0006935 and chemotaxis and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007264 and small GTPase mediated signal transduction and biological process this GO :0007411 and axon guidance and biological process this GO :0007596 and blood coagulation and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0010310 and regulation of hydrogen peroxide metabolic process and biological process this GO :0015031 and protein transport and biological process this GO :0016020 and membrane and cellular component this GO :0030031 and cell projection assembly and biological process this GO :0030036 and actin cytoskeleton organization and biological process this GO :0030168 and platelet activation and biological process this GO :0045087 and innate immune response and biological process this GO :0045453 and bone resorption and biological process this GO :0051056 and regulation of small GTPase mediated signal transduction and biological process this GO :0060263 and regulation of respiratory burst and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0003924 : GTPase activity, this GO :0003924 : GTPase activity and also this GO :0005525 : GTP binding, this GO :0004866 : endopeptidase inhibitor activity, this GO :0004866 : endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, this GO :0005102 : receptor binding, this GO :0005515 : protein binding, this GO :0005525 : GTP binding, this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, 12266, 19562 and IDBG-643930 and ENSBTAG00000017280 and 280677, ras-related C3 botulinum toxin substrate 2 (rho family |
| Identity: |
9802 |
| Gene: |
RAC2 |
More about : RAC2 |
| Long gene name: |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| Synonyms: |
EN-7 |
| Locus: |
22q13, 1 |
| Discovery year: |
1993-11-05 |
| GenBank acession: |
M64595 |
| Entrez gene record: |
5880 |
| Pubmed identfication: |
2674130 |
| Classification: |
Rho family GTPases Endogenous ligands |
| Havana BLAST/BLAT: |
OTTHUMG00000150540 |
| Locus Specific Databases: |
RAC2base: Mutation registry for Neutrophil immunodeficiency syndrome LRG_97 |